Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
In the latest session, CVS Health Corp (NYSE: CVS) closed at $67.45 up 0.40% from its previous closing price of $67.18. In other words, the price has increased by $0.40 from its previous closing price. On the day, 6.54 million shares were traded. CVS stock price reached its highest trading level at $67.875 during the session, while it also had its lowest trading level at $67.08.
Ratios:
For a deeper understanding of CVS Health Corp’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.35 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 8.17. For the most recent quarter (mrq), Quick Ratio is recorded 0.63 and its Current Ratio is at 0.86. In the meantime, Its Debt-to-Equity ratio is 1.04 whereas as Long-Term Debt/Eq ratio is at 0.98.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Barclays on March 06, 2024, initiated with a Equal Weight rating and assigned the stock a target price of $78.
On February 26, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $88.
On December 22, 2023, HSBC Securities started tracking the stock assigning a Buy rating and target price of $94.HSBC Securities initiated its Buy rating on December 22, 2023, with a $94 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Feb 16 ’24 when Shah Prem S sold 29,473 shares for $76.95 per share. The transaction valued at 2,267,947 led to the insider holds 39,765 shares of the business.
LUDWIG EDWARD J bought 2,000 shares of CVS for $140,930 on Nov 03 ’23. The Director now owns 20,630 shares after completing the transaction at $70.47 per share. On Aug 03 ’23, another insider, Clark James David, who serves as the SVP, Cont & Chief Acct Officer of the company, sold 25,759 shares for $74.92 each. As a result, the insider received 1,930,004 and left with 4,698 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CVS now has a Market Capitalization of 85019369472 and an Enterprise Value of 152987418624. As of this moment, CVS’s Price-to-Earnings (P/E) ratio for their current fiscal year is 10.43, and their Forward P/E ratio for the next fiscal year is 7.38. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.82. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.24 while its Price-to-Book (P/B) ratio in mrq is 1.14. Its current Enterprise Value per Revenue stands at 0.429 whereas that against EBITDA is 8.297.
Stock Price History:
The Beta on a monthly basis for CVS is 0.55, which has changed by -0.07297969 over the last 52 weeks, in comparison to a change of 0.24191546 over the same period for the S&P500. Over the past 52 weeks, CVS has reached a high of $83.25, while it has fallen to a 52-week low of $64.41. The 50-Day Moving Average of the stock is -9.29%, while the 200-Day Moving Average is calculated to be -7.21%.
Shares Statistics:
For the past three months, CVS has traded an average of 9.36M shares per day and 8025860 over the past ten days. A total of 1.29B shares are outstanding, with a floating share count of 1.26B. Insiders hold about 0.17% of the company’s shares, while institutions hold 81.97% stake in the company. Shares short for CVS as of 1713139200 were 17995667 with a Short Ratio of 1.92, compared to 1710460800 on 18644394. Therefore, it implies a Short% of Shares Outstanding of 17995667 and a Short% of Float of 1.43.
Dividends & Splits
According to the company, the forward annual dividend rate for CVS is 2.54, from 2.42 in the trailing year. Against a Trailing Annual Dividend Yield of 0.036022626The stock’s 5-year Average Dividend Yield is 2.86. The current Payout Ratio is 38.34% for CVS, which recently paid a dividend on 2024-04-19 with an ex-dividend date of 1713484800. Stock splits for the company last occurred on 2005-06-07 when the company split stock in a 2:1 ratio.
Earnings Estimates
The market rating for CVS Health Corp (CVS) is a result of the insights provided by 22.0 analysts actively involved in the assessment.On average, analysts expect EPS of $1.71 for the current quarter, with a high estimate of $2.02 and a low estimate of $1.63, while EPS last year was $2.2. The consensus estimate for the next quarter is $2.21, with high estimates of $2.34 and low estimates of $1.94.
Analysts are recommending an EPS of between $8.4 and $8.11 for the fiscal current year, implying an average EPS of $8.3. EPS for the following year is $9.16, with 25.0 analysts recommending between $9.53 and $8.9.
Revenue Estimates
A total of 18 analysts believe the company’s revenue will be $89.2B this quarter.It ranges from a high estimate of $91.18B to a low estimate of $87.42B. As of the current estimate, CVS Health Corp’s year-ago sales were $80.81BFor the next quarter, 18 analysts are estimating revenue of $92.08B. There is a high estimate of $93.49B for the next quarter, whereas the lowest estimate is $90.01B.
A total of 23 analysts have provided revenue estimates for CVS’s current fiscal year. The highest revenue estimate was $377.36B, while the lowest revenue estimate was $363.6B, resulting in an average revenue estimate of $370.82B. In the same quarter a year ago, actual revenue was $357.78BBased on 23 analysts’ estimates, the company’s revenue will be $392.61B in the next fiscal year. The high estimate is $401.28B and the low estimate is $384.03B.
